Inhibit cell death to save the myocardium and the patient's life during a heart attack
Member
Created in Toulouse in 2017, Sêmeia develops simple, intuitive and effective support solutions for patients suffering from serious or chronic illnesses.
Inhibit cell death to save the myocardium and...
Created in 2013 and based in Grabels (34) and Labège (31), ...
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from France have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically determined diseases.
Created in Toulouse in 2005, ABIONYX Pharma is a ...
La société Rofim, adhérente d'Eurobiomed, fait parti des 3 start-up française à intégrer le programme "Google for Startups".
The EFFI-CLIN project, of which the company HISTALIM is a partner, aims to offer a new cancer immunotherapy adapted to the immunological profile of each tumor according to the concept of personalized medicine by targeting a new generation of immune checkpoints.
Created in 2013, Phenocell is based in Grasse (06) in ...
REGEnLIFE is a medtech based in...
Created in 2021 in Nîmes, Panntherapi develops ...
Created in 2004 and based in Montpellier, Intrasense ...